标题
Evaluating bedaquiline as a treatment option for multidrug-resistant tuberculosis
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-7
出版商
Informa UK Limited
发表日期
2021-01-04
DOI
10.1080/14656566.2020.1867538
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TBAJ-876, a 3,5-dialkoxypyridine analogue of Bedaquiline, is active against Mycobacterium abscessus
- (2020) Jickky Palmae Sarathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
- (2020) Camus Nimmo et al. EUROPEAN RESPIRATORY JOURNAL
- Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates
- (2020) Irina V. Peretokina et al. JOURNAL OF INFECTION
- Actualización de la normativa SEPAR «Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos»
- (2020) José A. Caminero et al. ARCHIVOS DE BRONCONEUMOLOGIA
- The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa
- (2020) Abela Mpobela Agnarson et al. Expert Review of Anti-Infective Therapy
- Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis
- (2020) S. D. Masuku et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study
- (2020) M. Gao et al. CLINICAL MICROBIOLOGY AND INFECTION
- Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea
- (2020) Hyungseok Kang et al. RESPIRATORY MEDICINE
- Concurrent Use of Bedaquiline and Delamanid for the Treatment of Fluoroquinolone-resistant Multidrug-resistant Tuberculosis: A Nationwide Cohort Study in South Korea
- (2020) Yong-Soo Kwon et al. EUROPEAN RESPIRATORY JOURNAL
- TBAJ-876 retains Bedaquiline's activity against subunit c and ϵ of Mycobacterium tuberculosis F-ATP synthase
- (2019) Jickky Palmae Sarathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Management of patients with multidrug-resistant tuberculosis
- (2019) C. Lange et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity
- (2019) Harun Patel et al. TUBERCULOSIS
- Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
- (2019) Emanuele Pontali et al. European Respiratory Review
- Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis in the United States
- (2019) Sundari Mase et al. CLINICAL INFECTIOUS DISEASES
- The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
- (2019) Keertan Dheda et al. Lancet Respiratory Medicine
- Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
- (2019) Payam Nahid et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines
- (2019) José A. Caminero et al. EUROPEAN RESPIRATORY JOURNAL
- A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug resistant tuberculosis
- (2019) Olatunde Olayanju et al. EUROPEAN RESPIRATORY JOURNAL
- Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
- (2019) Sergey Borisov et al. EUROPEAN RESPIRATORY JOURNAL
- Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review
- (2018) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
- (2018) Olatunde Olayanju et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study
- (2018) Kathryn Schnippel et al. Lancet Respiratory Medicine
- Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
- (2018) Nafees Ahmad et al. LANCET
- Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
- (2018) Yang Li et al. DRUG DEVELOPMENT RESEARCH
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis – Authors' reply
- (2018) Norbert Ndjeka Lancet Respiratory Medicine
- Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence
- (2017) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
- (2017) Sergey E. Borisov et al. EUROPEAN RESPIRATORY JOURNAL
- Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline
- (2017) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?
- (2017) Amber Kunkel et al. LANCET INFECTIOUS DISEASES
- Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase
- (2016) Subhashri Kundu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis
- (2016) Giovanni Sotgiu et al. EUROPEAN RESPIRATORY JOURNAL
- Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
- (2016) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Drug–drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB
- (2016) Mishal Pandie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis
- (2016) T. V. A. Nguyen et al. Expert Review of Clinical Pharmacology
- Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
- (2015) Alexander S. Pym et al. EUROPEAN RESPIRATORY JOURNAL
- Bedaquiline
- (2014) Elias B. Chahine et al. ANNALS OF PHARMACOTHERAPY
- Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug
- (2014) Sarah C. McLeay et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
- (2014) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis
- (2014) Marylee V. Worley et al. PHARMACOTHERAPY
- Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial
- (2014) Andrew J Nunn et al. Trials
- Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls
- (2014) Ashish Kumar Kakkar et al. TUBERCULOSIS
- Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis
- (2011) Marie-Claude Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
- (2008) Anil Koul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More